National Healthcare Stock Beta
| NHC Stock | USD 125.20 0.73 0.59% |
National HealthCare fundamentals help investors to digest information that contributes to National HealthCare's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National HealthCare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National HealthCare stock.
National | Beta |
National HealthCare Company Beta Analysis
National HealthCare's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current National HealthCare Beta | 0.43 |
Most of National HealthCare's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National HealthCare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
National Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for National HealthCare is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Beta. Since National HealthCare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National HealthCare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National HealthCare's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, National HealthCare has a Beta of 0.428. This is 50.23% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
National Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National HealthCare's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National HealthCare could also be used in its relative valuation, which is a method of valuing National HealthCare by comparing valuation metrics of similar companies.National HealthCare is currently under evaluation in beta category among its peers.
National HealthCare Current Valuation Drivers
We derive many important indicators used in calculating different scores of National HealthCare from analyzing National HealthCare's financial statements. These drivers represent accounts that assess National HealthCare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of National HealthCare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.3B | 1.0B | 1.0B | 1.4B | 1.3B | 1.3B | |
| Enterprise Value | 1.3B | 1.1B | 1.1B | 1.4B | 1.3B | 1.3B |
National HealthCare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National HealthCare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National HealthCare's managers, analysts, and investors.Environmental | Governance | Social |
As returns on the market increase, National HealthCare's returns are expected to increase less than the market. However, during the bear market, the loss of holding National HealthCare is expected to be smaller as well.
National Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0288 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.92 B | ||||
| Shares Outstanding | 15.44 M | ||||
| Shares Owned By Insiders | 19.61 % | ||||
| Shares Owned By Institutions | 61.42 % | ||||
| Number Of Shares Shorted | 343.19 K | ||||
| Price To Earning | 22.85 X | ||||
| Price To Book | 1.97 X | ||||
| Price To Sales | 1.58 X | ||||
| Revenue | 1.14 B | ||||
| Gross Profit | 388.11 M | ||||
| EBITDA | 131.1 M | ||||
| Net Income | 66.8 M | ||||
| Cash And Equivalents | 58.67 M | ||||
| Cash Per Share | 14.19 X | ||||
| Total Debt | 93.39 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 63.69 X | ||||
| Cash Flow From Operations | 111.22 M | ||||
| Short Ratio | 8.15 X | ||||
| Earnings Per Share | 7.99 X | ||||
| Target Price | 6.15 | ||||
| Number Of Employees | 13.12 K | ||||
| Beta | 0.43 | ||||
| Market Capitalization | 1.9 B | ||||
| Total Asset | 1.31 B | ||||
| Retained Earnings | 687.6 M | ||||
| Working Capital | 191.76 M | ||||
| Current Asset | 164.61 M | ||||
| Current Liabilities | 114.08 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 2.89 % | ||||
| Net Asset | 1.31 B | ||||
| Last Dividend Paid | 2.4 |
About National HealthCare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National HealthCare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National HealthCare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out National HealthCare Piotroski F Score and National HealthCare Altman Z Score analysis. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.021 | Dividend Share 2.4 | Earnings Share 7.99 | Revenue Per Share 79.613 | Quarterly Revenue Growth 0.179 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.